相关实验视频
Updated: Jul 21, 2025
08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
67.4K
卡尔蛋白蛋白,在炎症性肠病患者中抑郁症的生物标志物?
Miorita Melina Iordache1,2, Anca Mihaela Belu1,3, Sabina E Vlad4
1Faculty of Medicine, Ovidius University of Constanta, 1 Universitatii Alley, 900470 Constanta, Romania.
Medicina (Kaunas, Lithuania)
|July 29, 2023
概括
升高的calprotectin水平与炎症性肠病患者的抑郁症严重程度相关. 131μg/g或更高的calprotectin水平可能表明抑郁症,提供了潜在的查工具.
科学领域:
- 胃肠病学 胃肠病学
- 精神病学是一个精神病学.
- 生物标志物研究 生物标志物研究
背景情况:
- 肠道炎症的标志物calprotectin越来越多地与抑郁症有关.
- 了解肠道炎症和心理健康之间的关系对于整体的患者护理至关重要.
- 炎症性肠病 (IBD) 患者经常经历并发性抑郁症和焦虑症.
研究的目的:
- 调查便中calprotectin水平与抑郁症,焦虑症和生活质量的严重程度之间的关联,在东南欧的克罗恩病 (CD) 和性结肠炎 (UC) 患者中.
- 为了确定calprotectin是否可以作为IBD患者抑郁症的预测生物标志物.
主要方法:
- 一项涉及30名IBD患者 (CD和UC) 的横截面研究.
- 通过临床面试评估抑郁症 (PHQ-9),焦虑症 (GAD-7) 和生活质量 (EQ-5D).
- 使用便样本测量便calprotectin水平.
主要成果:
- 蛋白水平与抑郁症严重程度 (PHQ-9) 有显著的正相关性,与生活质量 (EQ-5D) 有负相关性.
- 抑郁症严重程度较高的患者 (轻度至中度严重) 与抑郁症最小的患者相比,显示出显著更高的calprotectin水平.
- 卡尔蛋白是抑郁症的独立预测剂,高水平 (≥131μg/g) 显示出82%的敏感性和70%的准确性来预测抑郁症.
结论:
- 便calprotectin水平与患有炎症性肠道疾病的患者的抑郁症严重程度有显著的相关性.
- 131μg/g的calprotectin值可以作为IBD患者抑郁症的有价值和可访问的查工具.
- 需要进一步的研究来探索向炎症在治疗IBD抑郁症中的治疗含义.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
355
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
355
01:30Inflammatory Bowel Disease II: Crohn's Disease
293
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
293
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
215
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
215
01:29Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
01:17Chronic Bowel Disorders: Introduction
485
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195